Investing

Adaptive Biotechnologies CFO Piskel sells $3343 in shares

Adaptive Biotechnologies (NASDAQ:ADPT) Chief Financial Officer Kyle Piskel sold 238 shares of common stock on November 17, 2025, at a price of $14.05, for a total transaction value of $3343. The stock ...
blogTO

Animation with Piskel for Kids

Kids will learn how to make a simple pixel animation using the online Piskel app. Piskel can be used to create simple game sprites (i.e., 2D images overlaid onto a scene), GIF animations, and ...
Seeking Alpha

Adaptive Biotechnologies raises 2026 MRD revenue view to $260M-$270M while targeting positive adjusted EBITDA and free cash flow by end of 2026

"We're off to a strong start to the year with accelerating momentum in MRD and disciplined execution across the company" (CEO & Co-Founder Chad Robins). "MRD revenue grew 53% year-over-year" and ...
GeekWire

kyle piskel

— Chad Cohen will step down as CFO of Adaptive Biotechnologies on Feb. 15. Prior to joining Adaptive in 2015,… Read More Subscribe to GeekWire's free newsletters to catch every headline Have a scoop ...
Investing

Adaptive Biotechnologies CFO Piskel sells $245,910 in shares

Adaptive Biotechnologies (NASDAQ:ADPT) Chief Financial Officer Kyle Piskel sold 18,672 shares of the company’s common stock on March 11, 2026, at a price of $13.17, for a total transaction value of ...